Elizabeth August, MD
Family Medicine · Ridgefield Park, NJNPI 1841519204
Payments from drug & device makers
Across 134 payments — averaging $88.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Myriad Women's Health, Inc.$10K
- Novo Nordisk$731
- Amarin Pharma, Inc.$189
- GSK$146
- Merck$134
- Gilead$119
- plus $565 from 18 others
What the payments were for
- Speaking & faculty fees$8,25070%
- Travel & lodging$1,56013%
- Food & beverage$2,02117%
- Education$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Myriad Women's Health, Inc. | 20 | $9,967 |
| Novo Nordisk | 54 | $731 |
| Amarin Pharma, Inc. | 2 | $189 |
| GSK | 7 | $146 |
| Merck | 3 | $134 |
| Gilead | 8 | $119 |
| Amgen | 7 | $94 |
| Mylan Specialty L.p. | 4 | $73 |
| Genentech USA, Inc. | 5 | $67 |
| Eisai Inc. | 4 | $49 |
| AbbVie | 3 | $44 |
| Pfizer | 2 | $30 |
| Currax Pharmaceuticals LLC | 3 | $27 |
| Cranial Technologies, Inc | 2 | $26 |
| Regeneron Healthcare Solutions, Inc. | 1 | $19 |
| Welch Allyn | 1 | $19 |
| Metuchen Pharmaceuticals | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Vivus LLC | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Lilly USA, LLC | 1 | $15 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Kaleo, Inc. | 1 | $14 |
| Sanofi Pasteur Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$11,851 in reported general payments places this provider in the 95th percentile of 2,084 family medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 28 | $207 |
| Amlodipine Besylate | 11 | $42 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Ridgefield Park
- Iyad BakerRidgefield Park$77K
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.